|
|
|
|
|
HONG KONG, Aug 2, 2017 - (ACN Newswire) - PuraPharm Corporation Limited ("PuraPharm" or the "Group", HKEX: 1498) is a leading Hong Kong-based Chinese medicine company specialising in the research and development, production and sale of Concentrated Chinese Medicine Granules ("CCMG") products under the "Nong's" brand.
 | | Guests of honour who participated in the ribbon-cutting act during the opening ceremony of Nong's (Nanning) Chinese Medicine Clinic operated by PuraPharm |
The Group has announced that its first-ever Nong's Chinese Medicine Clinic in Mainland China has commenced operation at Nanning in Guangxi Zhuang Autonomous Region on 31 July 2017. The "Guangxi-Hong Kong CEPA Cooperation Project and Nong's (Nanning) Chinese Medicine Clinic Opening Ceremony" has received support from various sectors, including leaders from relevant authorities of the Nanning Municipal, and representatives of various business partners, education institutions and professional associations. They presided at the ceremony to witness the Group's advancement toward a new chapter in its development.
The Group has recently obtained the Certificate for Medical Institutions to Practice from the National Health and Family Planning Commission of Guangxi Zhuang Autonomous Region, and is the first Hong Kong-funded medical institution to be granted approval to operate in Guangxi under the Mainland and Hong Kong Closer Economic Partnership Arrangement ("CEPA"). The Group intends to speed up its pace in opening Nong's Chinese medicine clinics in Mainland China by capitalising on its extensive clinical experience and providing unique Chinese medicine diagnosis and treatment services, as well as applying healthcare and medical big data to deliver advances in Chinese medicine diagnosis and treatment services to local residents.
Mr. Chan Yu Ling, Abraham, Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm, said, "We are delighted that our first-ever Nong's Chinese Medicine Clinic in China has been opened in Nanning, not only initiating the Group's replication of the successful model of Nong's Chinese Medicine Clinics in Hong Kong within Mainland China, but also representing a significant milestone for the Group's Mainland operations extending from R&D and production of CCMG products to Chinese medicine diagnostics services. In addition to expanding our investment in Nanning, we will open more Nong's Chinese medicine clinics elsewhere in China including Shanghai, with the aim to capture the huge demand for modern Chinese Medicine services within the country."
Photo Caption:
Guests of honour who participated in the ribbon-cutting act during the opening ceremony of Nong's (Nanning) Chinese Medicine Clinic operated by PuraPharm (From left to right):
1. Mr. Huang Shoujiang - Chairman of Kam Ling Development Company Limited
2. Mr. Huang Huansheng - Former Deputy Secretary, Counsel and Deputy Director-General of the Department of Commerce of Guangxi Zhuang Autonomous Region
3. Mr. Miao Jianhua - Party Member of the Guangxi Zhuang Autonomous Region Health and Family Planning Commission and Director of the Guangxi Botanical Garden of Medicinal Plants
4. Mr. Calvin Chan - Executive Director and Vice President of Nong's Clinic Operations and Development of PuraPharm
5. Mr. Zhao Hongming - Standing Committee Member of CPC Nanning Municipal Committee and Head of the United Front Work Department
6. Mr. Abraham Chan - Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm
7. Mr. Ou Tingjie - Deputy Director of the Committee for Liaison with Hong Kong, Macao, Taiwan and Overseas Chinese and Committee of Foreign Affairs of the Guangxi Zhuang Autonomous Region
8. Ms. Viola Man - Executive Director of PuraPharm
9. Mr. Lan Yizhou - Former Secretary-General of Guangxi Medical Merchant Association
10. Mr. Zhang Yiheng - Director of China Operations (Nanning) of PuraPharm
11. Mr. Yeung Wingtung - Executive Director of ENM Holdings Limited
About PuraPharm Corporation Limited
PuraPharm is a leading Hong Kong-based Chinese medicine company specialising in the research and development, production and sale of CCMG products which the Group markets under its "Nong's" brand. PuraPharm is the largest supplier of CCMG products in Hong Kong with a market share of 70% in terms of prescription revenue for the Hong Kong CCMG product market in 2014, according to the Euromonitor Report. The Group also sells a broad range of general Chinese healthcare products, such as PuraGold and Oncozac, which are essentially Chinese herbal supplements, on an OTC basis, targeting end-consumers. PuraPharm currently operates 59 Nong's clinics in Hong Kong, the largest Chinese medicine clinic chain in Hong Kong. PuraPharm's shares have been listed on the Main Board of the Stock Exchange of Hong Kong Limited since 8 July 2015 under the stock code 1498.
Media Enquiries:
Strategic Financial Relations Limited
Heidi So +852 2864 4826 heidi.so@sprg.com.hk
Fanny Yuen +852 2864 4853 fanny.yuen@sprg.com.hk
Jessica Siu +852 2114 2820 jessica.siu@sprg.com.hk
www.sprg.com.hk
Topic: Press release summary
Source: PuraPharm Corporation Limited
Sectors: Food & Beverage, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
